JP2024516023A5 - - Google Patents

Info

Publication number
JP2024516023A5
JP2024516023A5 JP2023567167A JP2023567167A JP2024516023A5 JP 2024516023 A5 JP2024516023 A5 JP 2024516023A5 JP 2023567167 A JP2023567167 A JP 2023567167A JP 2023567167 A JP2023567167 A JP 2023567167A JP 2024516023 A5 JP2024516023 A5 JP 2024516023A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound
acceptable salt
item
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023567167A
Other languages
English (en)
Japanese (ja)
Other versions
JP7828661B2 (ja
JP2024516023A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/027506 external-priority patent/WO2022235693A1/en
Publication of JP2024516023A publication Critical patent/JP2024516023A/ja
Publication of JP2024516023A5 publication Critical patent/JP2024516023A5/ja
Application granted granted Critical
Publication of JP7828661B2 publication Critical patent/JP7828661B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023567167A 2021-05-04 2022-05-03 避妊薬の化合物及び方法 Active JP7828661B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163184014P 2021-05-04 2021-05-04
US63/184,014 2021-05-04
US202263307943P 2022-02-08 2022-02-08
US63/307,943 2022-02-08
US202263326524P 2022-04-01 2022-04-01
US63/326,524 2022-04-01
PCT/US2022/027506 WO2022235693A1 (en) 2021-05-04 2022-05-03 Contraceptive compounds and methods

Publications (3)

Publication Number Publication Date
JP2024516023A JP2024516023A (ja) 2024-04-11
JP2024516023A5 true JP2024516023A5 (https=) 2025-05-09
JP7828661B2 JP7828661B2 (ja) 2026-03-12

Family

ID=81854578

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023567167A Active JP7828661B2 (ja) 2021-05-04 2022-05-03 避妊薬の化合物及び方法

Country Status (9)

Country Link
US (3) US11780828B2 (https=)
EP (1) EP4334309A1 (https=)
JP (1) JP7828661B2 (https=)
KR (1) KR20240004737A (https=)
AU (1) AU2022270088A1 (https=)
CA (1) CA3217096A1 (https=)
IL (1) IL308171A (https=)
MX (1) MX2023012958A (https=)
WO (1) WO2022235693A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7828661B2 (ja) * 2021-05-04 2026-03-12 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 避妊薬の化合物及び方法
WO2025251031A1 (en) * 2024-05-30 2025-12-04 Yourchoice Therapeutics, Inc. Contraceptive compounds and dosing for the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
CN1255396C (zh) * 1996-03-18 2006-05-10 卫材株式会社 含有稠环的羧酸衍生物
US7105566B2 (en) * 2002-10-22 2006-09-12 Allergan, Inc. Methods of treatment during vascular procedures
AU2015365738B2 (en) * 2014-12-19 2020-07-23 Galderma Research & Development Novel compounds, synthesis method thereof and use of same in medicine and in cosmetics
WO2017201200A1 (en) * 2016-05-19 2017-11-23 Orphagen Pharmaceuticals, Inc. Therapeutic compositions containing rar-alpha antagonists
WO2019014468A1 (en) * 2017-07-13 2019-01-17 Io Therapeutics, Inc. RECEPTOR SUBTYPE AND RETINOID COMPOUNDS AND SELECTIVE REXINOIDS OF A FUNCTION IN COMBINATION WITH IMMUNE MODULATORS FOR ANTICANCER IMMUNOTHERAPY
EP3709990A4 (en) * 2017-11-17 2021-12-01 The Regents of the University of California MANIPULATION OF THE RETIC ACID SIGNAL PATH
JP7828661B2 (ja) * 2021-05-04 2026-03-12 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 避妊薬の化合物及び方法

Similar Documents

Publication Publication Date Title
JP6527341B2 (ja) ポビドンヨード、眼科用組成物のための新規代替保存剤
RU2353393C2 (ru) Доставка активного лекарства к дальней области глаза посредством субконъюнктивальной или периокулярной доставки пролекарства
JP5393679B2 (ja) アレナウイルス感染症を治療するための抗ウイルス薬
CA2900373C (en) Methods of treating microbial infections, including mastitis
JP2024516023A5 (https=)
JP2022511732A5 (https=)
JP6845233B2 (ja) 組み合せ抗細菌組成物および短期抗細菌レジメン
CA2899321A1 (en) Fluorinated .alpha..nu.integrin antagonists
WO2008116890A2 (en) Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
MX2010013946A (es) Composiciones transdermicas farmaceuticas y metodo para tratar la inflamacion en ganado.
JP2007509952A (ja) ロテプレドノールエタボネートおよびトブラマイシンの局所眼科用懸濁液
JP2020510075A5 (https=)
CN101505797A (zh) 用于真菌感染的治疗的药物组合物
TWI429427B (zh) 輸送系統
ES2203889T3 (es) Tratamiento de infecciones protozoarias.
RU2007105450A (ru) Лечение и профилактика заболеваний и инфекций свиней и домашней птицы
AU2014326576B2 (en) A veterinary method for inducing emesis
US20050227949A1 (en) Compositions and methods for treatment of viral and bacterial infections
JPS63101352A (ja) 眼科治療用組成物
JP2024544075A (ja) ブルーリ潰瘍におけるマイコバクテリウム・ウルセランスの局所治療のための製剤及び方法
JP2019521134A (ja) 性感染症用組成物
JP2006117569A (ja) ステロイド依存性あるいはステロイド抵抗性潰瘍性大腸炎治療薬
JP2022538994A (ja) カンナビノイドを用いた抗菌薬投与方法
JP2002514208A (ja) 痴呆の治療及び予防におけるシクロオキシゲナーゼ−２阻害剤の使用方法
JP2000086517A (ja) アロディニア治療剤